Stryker Co. (NYSE:SYK) Shares Acquired by Annex Advisory Services LLC

Annex Advisory Services LLC grew its holdings in Stryker Co. (NYSE:SYK) by 17.7% during the 1st quarter, Holdings Channel reports. The firm owned 1,878 shares of the medical technology company’s stock after buying an additional 283 shares during the period. Annex Advisory Services LLC’s holdings in Stryker were worth $672,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of SYK. Burkett Financial Services LLC acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $25,000. Farmers & Merchants Trust Co of Chambersburg PA grew its position in shares of Stryker by 203.3% in the fourth quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. Rogco LP acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $30,000. DSM Capital Partners LLC acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $34,000. Finally, HBC Financial Services PLLC purchased a new position in shares of Stryker during the fourth quarter valued at approximately $37,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Evercore ISI upped their price objective on shares of Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Roth Mkm upped their price objective on shares of Stryker from $348.00 to $405.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Needham & Company LLC raised shares of Stryker from a “hold” rating to a “buy” rating and set a $392.00 price objective on the stock in a research note on Wednesday, May 22nd. Stifel Nicolaus upped their price objective on shares of Stryker from $350.00 to $375.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Finally, The Goldman Sachs Group assumed coverage on shares of Stryker in a research note on Thursday, May 30th. They set a “neutral” rating and a $372.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $370.58.

Stryker Price Performance

Stryker stock opened at $339.65 on Wednesday. Stryker Co. has a 52-week low of $249.98 and a 52-week high of $361.41. The firm has a fifty day moving average of $336.73 and a 200-day moving average of $332.95. The firm has a market capitalization of $129.39 billion, a P/E ratio of 38.77, a PEG ratio of 2.67 and a beta of 0.92. The company has a quick ratio of 0.99, a current ratio of 1.71 and a debt-to-equity ratio of 0.56.

Stryker (NYSE:SYK) last released its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.36 by $0.14. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The company had revenue of $5.24 billion during the quarter, compared to analyst estimates of $5.10 billion. During the same quarter in the prior year, the business earned $2.14 earnings per share. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. As a group, analysts predict that Stryker Co. will post 11.95 EPS for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be given a $0.80 dividend. This represents a $3.20 annualized dividend and a dividend yield of 0.94%. The ex-dividend date of this dividend is Friday, June 28th. Stryker’s payout ratio is currently 36.53%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.